May 2, 2017
Pancreatic beta cells help maintain normal blood glucose levels by producing the hormone insulin — the master regulator of energy (glucose). Impairment and the loss of beta cells interrupts insulin production, leading to type 1 and 2 diabetes. Using single-cell RNA sequencing, researchers at University of California San Diego School…
February 27, 2018
…how genes and proteins change in response to certain drugs. The work provides a better understanding of disease-causing mutations and could enable researchers to discover new uses for existing drug treatments.
March 19, 2013
Researchers at the University of California, San Diego School of Medicine are principal investigators in two of nine new grants approved today by the governing board of the California Institute for Regenerative Medicine (CIRM).
March 3, 2016
…and biology; cancer and drug development; and advanced energy research. Tsien will also deliver the keynote lecture for the cancer and drug-development sessions, and Yamanaka will deliver the keynote lecture for the regenerative medicine and biology sessions. “The second UC San Diego-Kyoto University Joint Symposium will feature some of the…
May 9, 2024
UC San Diego researchers found that, during the peak of the COVID-19 pandemic, people experiencing homelessness and people who inject drugs in San Diego and Tijuana often did not have access to drinking water, toilets, handwashing and showers.
December 4, 2014
…the advent of antiretroviral drugs (prescribed in the early stages of infection) can often render HIV/AIDS a chronic but livable condition. Patients can live relatively normal, full lives for decades after diagnosis and now, for the first time, there is a drug to prevent people from getting infected with HIV.…
August 5, 2013
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
August 15, 2012
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New…
September 20, 2019
Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.
January 24, 2020
Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction. In a new study, UC San Diego researchers found that opioid dependence produced permanent changes in the brains of rats.
